HOME Top Market Reports Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] Global Trends & Competitive Analysis to 2017

Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] Global Trends & Competitive Analysis to 2017

By: marketsandmarkets.com
Publishing Date: October 2012
Report Code: MD 1310

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasive procedures to diagnose and treat vascular disorders of the brain and spine. With the help of advanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tiny tubes) to treat many complex disorders. Normally these disorders are treated either by closing (embolization) or opening (recanalization) the abnormal vessels. The neurointerventional device market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

The neurointerventional devices market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of the global neurointerventional devices market, followed by support devices cerebral balloon angioplasty & stenting systems and neurothrombectomy devices in 2012.

The major driving factor for these markets involves gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

North America dominates the overall neurointerventional devices market. Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific and Latin American market.

The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Scope of the Report

This research report categorizes the neurointerventional device market for devices used in neurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coiling procedure and support devices.

Various neurointerventional devices are categorized into:

  • Neurothrombectomy procedure - Suction/aspiration device, clot retriever, and snare device
  • Cerebral angiography and stenting technique - Carotid stent, and embolic protection system
  • Aneurysm coiling procedure Platinum coil (Bare & Coated), Liquid embolic agents, and Flow diversion device.
  • Support devices - Microcatheter and Microguidewire

TABLE OF CONTENTS:

1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
      1.5.5 ASSUMPTIONS
 
2 EXECUTIVE SUMMARY
 
3 MARKET OVERVIEW

  3.1 INTRODUCTION
  3.2 MARKET SEGMENTATION
  3.3 MARKET DYNAMICS
      3.3.1 DRIVERS
            3.3.1.1 Advancements in technology
            3.3.1.2 Increasing aging & obese population
            3.3.1.3 Increasing number of ischemic & hemorrhagic stroke patients
            3.3.1.4 Growing demand for minimally invasive surgery
      3.3.2 RESTRAINTS
            3.3.2.1 Increasing complexity in clinical trials
            3.3.2.2 Decreasing average selling prices
            3.3.2.3 Hospital budget constraints& alternative treatment facilities
      3.3.3 THREATS & OPPORTUNITIES
  3.4 TRENDS
  3.5 UPCOMING TECHNOLOGIES
  3.6 MARKET SHARE ANALYSIS
 
4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY TECHNIQUES
  4.1 INTRODUCTION
  4.2 NEUROTHROMBECTOMY
  4.3 CAROTID ARTERY ANGIOGRAPHY & STENTING
  4.4 EMBOLIZATION OF ARTERIOVENOUS MALFORMATION ARTERIOVENOUS FISTULA
  4.5 COILING PROCEDURE
 
5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCTS
  5.1 NEUROTHROMBECTOMY DEVICES
      5.1.1 INTRODUCTION
      5.1.2 SUCTION/ASPIRATION DEVICES
      5.1.3 CLOT RETRIEVER
      5.1.4 SNARE
  5.2 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS
      5.2.1 INTRODUCTION
      5.2.2 CAROTID ARTERY STENTS
      5.2.3 EMBOLIC PROTECTION SYSTEMS
            5.2.3.1 Distal filter devices
            5.2.3.2 Balloon occlusion devices
  5.3 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION
      5.3.1 INTRODUCTION
      5.3.2 EMBOLIC COIL
            5.3.2.1 Bare Platinum Detachable Coil
            5.3.2.2 Coated Detachable Coil
      5.3.3 LIQUID EMBOLIC AGENTS
      5.3.4 FLOW DIVERSION DEVICE
  5.4 SUPPORT DEVICES
      5.4.1 INTRODUCTION
      5.4.2 MICROCATHETER
      5.4.3 MICROGUIDEWIRE
 
6 GEOGRAPHIC ANALYSIS
  6.1 INTRODUCTION
  6.2 NORTH AMERICA
  6.3 EUROPE
  6.4 ASIA
  6.5 REST OF THE WORLD (ROW)
 
7 COMPETITIVE LANDSCAPE
  7.1 MERGERS & ACQUISITIONS
  7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
  7.3 NEW PRODUCT LAUNCH
  7.4 APPROVAL
  7.5 EXPANSION
  7.6 OTHER DEVELOPMENTS
 
8 COMPANY PROFILES
  8.1 ABBOTT LABORATORIES
      8.1.1 OVERVIEW
      8.1.2 FINANCIALS
      8.1.3 PRODUCTS & SERVICES
      8.1.4 STRATEGY
      8.1.5 DEVELOPMENTS
  8.2 BAYER AG
      8.2.1 OVERVIEW
      8.2.2 FINANCIAL
      8.2.3 PRODUCTS & SERVICES
      8.2.4 STRATEGY
      8.2.5 DEVELOPMENTS
  8.3 COAXIA, INC.
      8.3.1 OVERVIEW
      8.3.2 FINANCIALS
      8.3.3 PRODUCTS & SERVICES
      8.3.4 STRATEGY
      8.3.5 DEVELOPMENTS
  8.4 COVIDIEN, PLC
      8.4.1 OVERVIEW
      8.4.2 FINANCIALS
      8.4.3 PRODUCTS & SERVICES
      8.4.4 STRATEGY
      8.4.5 DEVELOPMENTS
  8.5 JOHNSON & JOHNSON
      8.5.1 OVERVIEW
      8.5.2 FINANCIALS
      8.5.3 PRODUCTS & SERVICES
      8.5.4 STRATEGY
      8.5.5 DEVELOPMENTS
  8.6 MERIT MEDICAL SYSTEMS, INC.
      8.6.1 OVERVIEW
      8.6.2 FINANCIALS
      8.6.3 PRODUCTS & SERVICES
      8.6.4 STRATEGY
      8.6.5 DEVELOPMENTS
  8.7 NEUROINTERVENTIONAL THERAPEUTICS, INC. (NIT)
      8.7.1 OVERVIEW
      8.7.2 FINANCIALS
      8.7.3 PRODUCTS & SERVICES
      8.7.4 STRATEGY
      8.7.5 DEVELOPMENTS
  8.8 NFOCUS NEUROMEDICAL, INC.
      8.8.1 OVERVIEW
      8.8.2 FINANCIALS
      8.8.3 PRODUCTS & SERVICES
      8.8.4 STRATEGY
      8.8.5 DEVELOPMENTS
  8.9 PENUMBRA, INC.
      8.9.1 OVERVIEW
      8.9.2 FINANCIALS
      8.9.3 PRODUCTS & SERVICES
      8.9.4 STRATEGY
      8.9.5 DEVELOPMENTS
  8.10 REVERSE MEDICAL CORPORATION
       8.10.1 OVERVIEW
       8.10.2 FINANCIALS
       8.10.3 PRODUCTS & SERVICES
       8.10.4 STRATEGY
       8.10.5 DEVELOPMENTS
  8.11 STRYKER CORPORATION
       8.11.1 OVERVIEW
       8.11.2 FINANCIALS
       8.11.3 PRODUCTS & SERVICES
       8.11.4 STRATEGY
       8.11.5 DEVELOPMENTS
  8.12 TERUMO CORPORATION
       8.12.1 OVERVIEW
       8.12.2 FINANCIALS
       8.12.3 PRODUCTS & SERVICES
       8.12.4 STRATEGY
       8.12.5 DEVELOPMENTS
  8.13 VALOR MEDICAL, INC.
       8.13.1 OVERVIEW
       8.13.2 FINANCIALS
       8.13.3 PRODUCTS & SERVICES
       8.13.4 STRATEGY
       8.13.5 DEVELOPMENTS
  8.14 W.L.GORE & ASSOCIATES, INC.
       8.14.1 OVERVIEW
       8.14.2 FINANCIALS
       8.14.3 PRODUCTS & SERVICES
       8.14.4 STRATEGY
       8.14.5 DEVELOPMENTS
 
 
LIST OF TABLES
 
TABLE 1 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 2 UPCOMING TECHNOLOGY: PHASE IV CLINICAL TRIAL STUDY
TABLE 3 UPCOMING TECHNOLOGY: PHASE III CLINICAL TRIAL STUDY
TABLE 4 UPCOMING TECHNOLOGY: PHASE II CLINICAL TRIAL STUDY
TABLE 5 UPCOMING TECHNOLOGY: PHASE I CLINICAL TRIAL STUDY
TABLE 6 UPCOMING TECHNOLOGY: 510 (K) APPROVAL
TABLE 7 UPCOMING TECHNOLOGY: OTHERS CLINICAL TRIAL STUDY
TABLE 8 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 9 GLOBAL NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 10 NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 11 GLOBAL CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 12 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 13 GLOBAL ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 14 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 15 SUCTION/ASPIRATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 16 SUCTION/ASPIRATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 17 CLOT RETRIEVER MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 18 CLOT RETRIEVER MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 19 SNARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 20 SNARE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 21 CAROTID ARTERY STENTS MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 22 CAROTID ARTERY STENTS MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 23 EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 24 EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 25 DISTAL FILTER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 26 DISTAL FILTER DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 27 BALLOON OCCLUSION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 28 BALLOON OCCLUSION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 29 GLOBAL EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 30 EMBOLIC COIL MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 31 EMBOLIC COIL MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 32 BARE PLATINUM DETACHABLE COIL MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 33 BARE PLATINUM DETACHABLE COIL MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 34 COATED DETACHABLE COIL MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 35 COATED DETACHABLE COIL MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 36 LIQUID EMBOLIC AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 37 LIQUID EMBOLIC AGENTS MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 38 FLOW DIVERSION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 39 FLOW DIVERSION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 40 GLOBAL SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 41 SUPPORT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 42 MICROCATHETERS MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 43 MICROCATHETERS MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 44 MICROGUIDEWIRES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 45 MICROGUIDEWIRES MARKET VOLUME, BY GEOGRAPHY, 2010 2017 (NO. OF UNITS)
TABLE 46 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 47 NORTH AMERICA: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 48 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 49 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 50 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 51 NORTH AMERICA: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 52 NORTH AMERICA: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 53 NORTH AMERICA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 54 NORTH AMERICA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 55 NORTH AMERICA: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 56 NORTH AMERICA: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 57 NORTH AMERICA: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 58 NORTH AMERICA: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 59 EUROPE: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 60 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 61 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 62 EUROPE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 63 EUROPE: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 64 EUROPE: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 65 EUROPE: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 66 EUROPE: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 67 EUROPE: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 68 EUROPE: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 69 EUROPE: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 70 EUROPE: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 71 ASIA: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 72 ASIA: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 73 ASIA: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 74 ASIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 75 ASIA: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 76 ASIA: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 77 ASIA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 78 ASIA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 79 ASIA: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 80 ASIA: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 81 ASIA: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 82 ASIA: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 83 ROW: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 84 ROW: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 85 ROW: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 86 ROW: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 87 ROW: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 88 ROW: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 89 ROW: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 90 ROW: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 91 ROW: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 92 ROW: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 93 ROW: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 94 ROW: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 2017 (NO. OF UNITS)
TABLE 95 MERGERS & ACQUISITIONS, 2009 2012
TABLE 96 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 2012
TABLE 97 NEW PRODUCT LAUNCH, 2009 2012
TABLE 98 APPROVAL, 2009 2012
TABLE 99 EXPANSION, 2009 2012
TABLE 100 OTHER DEVELOPMENTS, 2009 2012
TABLE 101 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2009 2011 ($MILLION)
TABLE 102 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 103 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 104 BAYER AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 105 BAYER AG: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 106 BAYER AG: HEALTHCARE TOTAL REVENUE, BY DIVISIONS, 2009 2011 ($MILLION)
TABLE 107 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 108 BAYER AG: TOTAL REVENUE OF HEALTHCARE DIVISION, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 109 COVIDIEN, PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 2011 ($MILLION)
TABLE 110 COVIDIEN, PLC: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 111 COVIDIEN, PLC: MEDICAL DEVICES TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 112 COVIDIEN, PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 114 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 115 JOHNSON AND JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY DIVISIONS, 2009 2011 ($MILLION)
TABLE 116 JOHNSON AND JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 117 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 118 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 201 ($MILLION)
TABLE 119 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 120 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 2011 ($MILLION)
TABLE 121 STRYKER CORPORATION: TOTAL REVENUES, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 122 STRYKER CORPORATION: NEUROTECHNOLOGY AND SPINE SEGMENT TOTAL REVENUE, 2009 2011 ($MILLION)
TABLE 123 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 124 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 125 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 126 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
 
 
LIST OF FIGURES
 
FIGURE 1 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE, 2012 & 2017
FIGURE 2 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2012
FIGURE 3 NEUROINTERVENTIONAL DEVICES MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 GLOBAL NEUROINTERVENTIONAL MARKET SHARE, BY PLAYERS, 2012
FIGURE 6 NEUROTHROMBECTOMY DEVICES SEGMENTATION
FIGURE 7 NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT SEGMENTS, 2012 & 2017
FIGURE 8 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SEGMENTATION
FIGURE 9 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION DEVICES SEGMENTATION
FIGURE 10 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT SEGMENTS, 2012 & 2017
FIGURE 11 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET SHARE, BY GROWTH STRATEGIES, 2009 2012

Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasive procedures to diagnose and treat vascular disorders of the brain and spine. With the help of advanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tiny tubes) to treat many complex disorders. Normally these disorders are treated either by closing (embolization) or opening (recanalization) the abnormal vessels. The neurointerventional device market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of the global neurointerventional devices market, followed by support devices, cerebral balloon angioplasty & stenting systems and Neurothrombectomy devices in 2012.

Gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures are the major drivers that are slated to propel this market. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

North America commands for the largest share of the global neurointerventional devices market in 2012. Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries.

The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Global Neurointerventional Devices Market Share Analysis, By Key Players, 2012

Neurointerventional Devices Market, Interventional Neurology Market 

Source: Expert Interviews, MnM Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports